METHOD FOR PRODUCING NEURAMINIC ACID DERIVATIVE
    71.
    发明公开
    METHOD FOR PRODUCING NEURAMINIC ACID DERIVATIVE 审中-公开
    生产神经氨酸衍生物的方法

    公开(公告)号:EP2960237A1

    公开(公告)日:2015-12-30

    申请号:EP15174323.4

    申请日:2012-12-13

    IPC分类号: C07D309/28

    摘要: The present invention provides a method for manufacturing a compound (10):

    by reacting a compound (7):

    with triphenylphosphine followed by reacting with a base and water to produce a compound (8):

    and adding an acid to an aqueous solution containing the compound (8) to remove carbonic acid and reacting the compound represented by the formula (8) with a compound (9):

    in the aqueous solution from which carbonic acid has been removed.

    摘要翻译: 本发明提供了制备化合物(10)的方法:使化合物(7):与三苯基膦反应,然后与碱和水反应以产生化合物(8):和将酸加入到含有 化合物(8)除去碳酸,使化学式(8)所示的化合物与化合物(9)反应:除去了碳酸的水溶液中。

    Method for proliferating cardiomyocytes using micro-RNA
    79.
    发明公开
    Method for proliferating cardiomyocytes using micro-RNA 审中-公开
    Verfahren zur Proliferation von Cardiomyozyten mithilfe von Mikro-RNA

    公开(公告)号:EP2842577A1

    公开(公告)日:2015-03-04

    申请号:EP14189625.8

    申请日:2011-03-11

    摘要: The present invention addresses the problems of providing a method for proliferating cardiomyocytes using a miRNA that promotes the proliferation of cardiomyocytes, a vector for use in the treatment of heart disease, a pharmaceutical composition for treating heart disease, and so forth.
    The present invention provides a method for proliferating cardiomyocytes using a miRNA having the cardiomyocyte proliferation promoting action, a vector for use in the treatment of heart disease that comprises said miRNA, a pharmaceutical composition for treating heart disease that comprises said vector, and so forth. A particularly preferred miRNA is one that is selected from the group consisting of mature miRNAs, i.e., miR-148a, miR-148b, miR-152, and miR-373, and precursors of said miRNAs, as well as variants and analogs thereof.

    摘要翻译: 本发明解决了提供使用促进心肌细胞增殖的miRNA增殖心肌细胞的方法,用于治疗心脏病的载体,用于治疗心脏病的药物组合物等的问题。 本发明提供使用具有心肌细胞增殖作用的miRNA增殖心肌细胞的方法,用于治疗心脏病的载体,其包含所述miRNA,用于治疗包括所述载体的心脏病的药物组合物等。 特别优选的miRNA是选自成熟miRNA,即miR-148a,miR-148b,miR-152和miR-373以及所述miRNA的前体以及其变体和类似物的miRNA。